NACCHIO, MARIANTONIA
 Distribuzione geografica
Continente #
AS - Asia 1.961
NA - Nord America 1.703
EU - Europa 1.671
SA - Sud America 232
AF - Africa 44
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 3
Totale 5.620
Nazione #
US - Stati Uniti d'America 1.635
SG - Singapore 812
RU - Federazione Russa 700
IT - Italia 453
VN - Vietnam 419
CN - Cina 312
BR - Brasile 185
HK - Hong Kong 180
DE - Germania 121
NL - Olanda 76
FR - Francia 67
GB - Regno Unito 60
IN - India 56
FI - Finlandia 42
CA - Canada 35
BD - Bangladesh 31
JP - Giappone 29
KR - Corea 28
AR - Argentina 26
ES - Italia 23
MX - Messico 23
GR - Grecia 18
PL - Polonia 18
UA - Ucraina 18
CI - Costa d'Avorio 14
IQ - Iraq 13
PH - Filippine 13
AT - Austria 12
LT - Lituania 12
EC - Ecuador 11
ZA - Sudafrica 11
IE - Irlanda 10
SE - Svezia 10
TH - Thailandia 9
PK - Pakistan 8
UZ - Uzbekistan 8
TR - Turchia 6
TW - Taiwan 6
AU - Australia 5
CZ - Repubblica Ceca 5
EG - Egitto 5
ID - Indonesia 5
RO - Romania 5
BE - Belgio 4
SA - Arabia Saudita 4
CO - Colombia 3
JO - Giordania 3
MY - Malesia 3
TN - Tunisia 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
AZ - Azerbaigian 2
BG - Bulgaria 2
BS - Bahamas 2
CL - Cile 2
DZ - Algeria 2
HN - Honduras 2
JM - Giamaica 2
KZ - Kazakistan 2
RS - Serbia 2
SI - Slovenia 2
SY - Repubblica araba siriana 2
UY - Uruguay 2
VE - Venezuela 2
XK - ???statistics.table.value.countryCode.XK??? 2
AD - Andorra 1
BF - Burkina Faso 1
BY - Bielorussia 1
CH - Svizzera 1
CU - Cuba 1
CY - Cipro 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
EE - Estonia 1
ET - Etiopia 1
EU - Europa 1
GA - Gabon 1
GE - Georgia 1
GH - Ghana 1
GT - Guatemala 1
HU - Ungheria 1
KE - Kenya 1
KG - Kirghizistan 1
KH - Cambogia 1
LV - Lettonia 1
MA - Marocco 1
MD - Moldavia 1
MM - Myanmar 1
NG - Nigeria 1
NI - Nicaragua 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PE - Perù 1
PS - Palestinian Territory 1
SC - Seychelles 1
SK - Slovacchia (Repubblica Slovacca) 1
TJ - Tagikistan 1
YT - Mayotte 1
Totale 5.620
Città #
Singapore 391
San Jose 324
Hong Kong 173
Ashburn 157
Moscow 149
Chandler 123
Naples 121
Ho Chi Minh City 117
Beijing 105
Hanoi 102
Hefei 69
Los Angeles 61
Munich 58
Santa Clara 58
The Dalles 50
Amsterdam 41
Lauterbourg 39
New York 37
Millbury 29
Helsinki 26
Lawrence 26
Des Moines 24
Tokyo 22
Boston 21
Kochi 21
Milan 21
Rome 21
Buffalo 20
São Paulo 20
Napoli 18
Redondo Beach 18
Dallas 17
Haiphong 17
Frankfurt am Main 16
Seoul 16
Falkenstein 14
Heraklion 14
Warsaw 14
Da Nang 13
Montreal 13
Orem 13
Wilmington 13
London 12
Atlanta 10
Chicago 10
Fairfield 10
Turku 10
Valencia 10
Baghdad 9
Biên Hòa 9
Brooklyn 9
Council Bluffs 9
Johannesburg 8
Phoenix 8
San Francisco 8
Seattle 8
Toronto 8
Boardman 7
Denver 7
Houston 7
Mexico City 7
Redwood City 7
Salerno 7
Salt Lake City 7
Tashkent 7
Can Tho 6
Casalnuovo di Napoli 6
Chennai 6
Grosseto 6
Hải Dương 6
Nanjing 6
Nuremberg 6
Portsmouth 6
Rio de Janeiro 6
Roubaix 6
Stockholm 6
Woodbridge 6
Dublin 5
Memphis 5
Messina 5
Miami 5
Monterrey 5
Piscataway 5
Poplar 5
Quito 5
Vienna 5
Ankara 4
Buenos Aires 4
Charlotte 4
Dhaka 4
Düsseldorf 4
Guayaquil 4
Lappeenranta 4
Lucca 4
Madrid 4
Ottawa 4
Pomigliano d'Arco 4
Princeton 4
Afragola 3
Bexley 3
Totale 2.987
Nome #
Performance analysis of SiRe next-generation sequencing panel in diagnostic setting: focus on NSCLC routine samples 223
Cell free DNA analysis by SiRe® next generation sequencing panel in non small cell lung cancer patients: focus on basal setting. 188
Technical Validation of a Fully Integrated NGS Platform in the Real-World Practice of Italian Referral Institutions 162
Non-Small Cell Lung Cancer Testing on Reference Specimens: An Italian Multicenter Experience 157
Rapid On-site Molecular Evaluation in thyroid cytopathology: A same-day cytological and molecular diagnosis 156
Performance evaluation of a fully closed real-time PCR platform for the detection of KRAS p.G12C mutations in liquid biopsy of patients with non-small cell lung cancer 155
Different qualifiers of AUS/FLUS thyroid FNA have distinct BRAF, RAS, RET/PTC, and PAX8/PPARg alterations. 154
Evaluation of the Molecular Landscape in PD-L1 Positive Metastatic NSCLC: Data from Campania, Italy 148
Predictive molecular pathology in metastatic thyroid cancer: the role of RET fusions 145
RNA-based next generation sequencing in non-small-cell lung cancer in a routine setting: an experience from an Italian referral center 143
RNA-Based Assay for Next-Generation Sequencing of Clinically Relevant Gene Fusions in Non-Small Cell Lung Cancer 138
Evaluation of BRAF, RAS, RET/PTC, and PAX8/PPARg alterations in different Bethesda diagnostic categories: A multicentric prospective study on the validity of the 7-gene panel test in 1172 thyroid FNAs deriving from different hospitals in South Italy 137
Moving towards a local testing solution for undetermined thyroid fine-needle aspirates: validation of a novel custom DNA-based NGS panel 137
Multiplex digital colour-coded barcode technology on RNA extracted from routine cytological samples of patients with non-small cell lung cancer: pilot study 136
Liquid biopsy for BRAF mutations testing in non-small cell lung cancer: A retrospective study 133
Next generation sequencing in cytology 131
Predictive molecular pathology in the time of COVID-19 129
Methods for actionable gene fusion detection in lung cancer: now and in the future 128
Harmonization of Next-Generation Sequencing Procedure in Italian Laboratories: A Multi-Institutional Evaluation of the SiRe® Panel 125
KRAS mutations testing in non-small cell lung cancer: The role of Liquid biopsy in the basal setting 123
Brca1/2 ngs somatic testing in clinical practice: a short report 121
Evaluation of Micro Satellite Instability and Mismatch Repair Status in Different Solid Tumors: A Multicenter Analysis in a Real World Setting 120
Multiple predictive biomarker testing in melanoma: another challenge for the optimal approach on cytological samples 119
The evolving role of interventional cytopathology from thyroid FNA to NGS: Lessons learned at Federico II University of Naples 119
Next Generation Sequencing in Cytopathology: Focus on Non-Small Cell Lung Cancer 119
Tumor mutational burden on cytological samples: A pilot study 118
Thyroid fine-needle aspiration trends before, during, and after the lockdown: what we have learned so far from the COVID-19 pandemic 118
BRAF: A Two-Faced Janus 118
How Molecular and Ancillary Tests Can Help in Challenging Cytopathology Cases: Insights from the International Molecular Cytopathology Meeting 117
Innovation in next-generation sequencing in non-Small cell lung cancer diagnostics 116
A challenging case of enteric-type lung adenocarcinoma metastatic to the thyroid harboring RET-fusion diagnosed on fine-needle aspiration 114
Liquid Biopsy Analysis in Clinical Practice: Focus on Lung Cancer 114
Liquid biopsy is a promising tool for genetic testing in idiopathic pulmonary fibrosis 113
Evaluating local thyroid cytopathology practices by molecular quality metrics: A multi‐institutional study on 4651 FNAs with a focus on the role of the interventional cytopathologist 113
Microfluidic chip technology applied to fine-needle aspiration cytology samples for IGH clonality assessment 111
Fine-Needle Aspiration Is Suitable for Breast Cancer BRCA Molecular Assessment: A Case Report 110
Microsatellite instability evaluation of patients with solid tumour: routine practice insight from a large series of Italian referral centre 110
Invited review—next-generation sequencing: a modern tool in cytopathology 109
Did selective kinase inhibitors change the management of patients with radioiodine-refractory thyroid cancer? 105
Young investigator challenge: Can the Ion AmpliSeq Cancer Hotspot Panel v2 be used for next-generation sequencing of thyroid FNA samples? 105
TargetPlex FFPE-Direct DNA Library Preparation Kit for SiRe NGS panel: an international performance evaluation study 104
RNA-Based Next-Generation Sequencing in Non-Small Cell Lung Cancer patients: data from Campania, Italy 97
Harmonization trial on ESR1 testing strategies in ER+/HER2- breast cancer patients: an Italian experience 93
Molecular Testing of Thyroid Fine-Needle Aspiration: Local Issues and Solutions. An Interventional Cytopathologist Perspective 93
Liquid biopsy for lung cancer: A cross section on the diagnostic routine experience of a referral Italian institution 39
Artificial Intelligence in Thyroid Cytopathology: Diagnostic and Technical Insights 26
Analytical reliability of cell-free DNA from fine-needle aspiration rinses for BRAF and NRAS testing in metastatic melanoma 15
PIK3CA testing in HR+/HER2− metastatic breast cancer: assessing pathology laboratories capacity and needs 8
Next-generation sequencing using a targeted gene panel in advanced solid tumors: five years of experience from an Italian referral institution 4
Totale 5.716
Categoria #
all - tutte 17.335
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.335


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20219 0 0 0 0 0 0 0 0 0 0 0 9
2021/2022255 8 5 9 8 3 9 2 16 16 38 70 71
2022/2023314 31 13 14 11 49 47 3 30 60 33 19 4
2023/2024235 19 49 19 13 9 13 7 27 11 15 25 28
2024/20251.531 57 62 4 9 41 76 133 110 67 236 589 147
2025/20263.153 289 267 347 278 514 152 350 163 393 236 123 41
Totale 5.716